# Clean Energy Technologies, Inc.: financial statements, quarterly

CETY · Nasdaq · CIK 1329606 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cety.md) · [Financials](/companies/cety/financials.md) · [Filings](/companies/cety/filings.md) · [Insiders](/companies/cety/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cety/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,004](/filings/0001493152-24-046866.md) | [1,416 d](/filings/0001493152-26-027379.md) | [1,513](/filings/0001493152-26-027401.md) | [196](/filings/0001493152-26-027404.md) | [235](/filings/0001493152-26-027406.md) | [480 d](/filings/0001493152-26-027409.md) | [442](/filings/0001493152-26-034674.md) | [236](/filings/0001493152-26-039170.md) | [774](/filings/0001493152-26-027406.md) | [710 d](/filings/0001493152-26-027409.md) | [784](/filings/0001493152-26-034674.md) | [372](/filings/0001493152-26-039170.md) |
| Cost of revenue | $k | [1,455](/filings/0001493152-24-046866.md) | [1,948 d](/filings/0001493152-26-027379.md) | [1,260](/filings/0001493152-26-027401.md) | [20.1](/filings/0001493152-26-027404.md) | [22.6](/filings/0001493152-26-027406.md) | [275 d](/filings/0001493152-26-027409.md) | [30.1](/filings/0001493152-26-034674.md) | [12.6](/filings/0001493152-26-039170.md) | [590](/filings/0001493152-26-027406.md) | [933 d](/filings/0001493152-26-027409.md) | [798](/filings/0001493152-26-034674.md) | [354](/filings/0001493152-26-039170.md) |
| Gross profit | $k | [549](/filings/0001493152-24-046866.md) | [(532) d](/filings/0001493152-26-027379.md) | [253](/filings/0001493152-26-027401.md) | [176](/filings/0001493152-26-027404.md) | [213](/filings/0001493152-26-027406.md) | [205 d](/filings/0001493152-26-027409.md) | [412](/filings/0001493152-26-034674.md) | [224](/filings/0001493152-26-039170.md) | [183](/filings/0001493152-26-027406.md) | [(223) d](/filings/0001493152-26-027409.md) | [(13.9)](/filings/0001493152-26-034674.md) | [17.6](/filings/0001493152-26-039170.md) |
| Research and development | $k | [0.0](/filings/0001493152-23-041332.md) | [0.0 d](/filings/0001493152-26-027379.md) | [0.0](/filings/0001493152-26-027401.md) | [0.0 d](/filings/0001493152-26-027404.md) | [0.0 d](/filings/0001493152-26-027406.md) | [0.0 d](/filings/0001493152-26-027409.md) | [0.0](/filings/0001493152-26-034674.md) | [0.0 d](/filings/0001493152-26-027404.md) | [0.0 d](/filings/0001493152-26-027406.md) | [0.0 d](/filings/0001493152-26-027409.md) | [0.0](/filings/0001493152-26-034674.md) | not reported |
| Operating income | $k | [(415)](/filings/0001493152-24-046866.md) | [(1,456) d](/filings/0001493152-26-027379.md) | [(821)](/filings/0001493152-26-027401.md) | [(974)](/filings/0001493152-26-027404.md) | [(759)](/filings/0001493152-26-027406.md) | [(779) d](/filings/0001493152-26-027409.md) | [(413)](/filings/0001493152-26-034674.md) | [(718)](/filings/0001493152-26-039170.md) | [(1,335)](/filings/0001493152-26-027406.md) | [(76.9) d](/filings/0001493152-26-027409.md) | [(719)](/filings/0001493152-26-034674.md) | [(756)](/filings/0001493152-26-039170.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [13.5](/filings/0001493152-26-027404.md) | not reported | not reported | not reported | not reported |
| Income tax | $k | [6.2](/filings/0001493152-23-041332.md) | [13.2 d](/filings/0001493152-26-027379.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-034674.md) | [0.0 d](/filings/0001493152-26-039170.md) | [0.0 d](/filings/0001493152-26-027406.md) | not reported | [0.8](/filings/0001493152-26-034674.md) | [(0.0)](/filings/0001493152-26-039170.md) |
| Net income | $k | [(721)](/filings/0001493152-24-046866.md) | [(3,058) d](/filings/0001493152-26-027379.md) | [(1,407)](/filings/0001493152-26-027401.md) | [(819)](/filings/0001493152-26-027404.md) | [(1,286)](/filings/0001493152-26-027406.md) | [(1,039) d](/filings/0001493152-26-027409.md) | [(660)](/filings/0001493152-26-039170.md) | [(1,040)](/filings/0001493152-26-039170.md) | [(1,997)](/filings/0001493152-26-027406.md) | [(3,096) d](/filings/0001493152-26-027409.md) | [(662)](/filings/0001493152-26-039170.md) | [(1,073)](/filings/0001493152-26-039170.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001493152-24-046866.md) | not reported | [(0.54)](/filings/0001493152-26-027401.md) | [(0.29)](/filings/0001493152-26-027404.md) | [(0.41)](/filings/0001493152-26-027406.md) | not reported | [(0.21)](/filings/0001493152-26-034674.md) | [(0.27)](/filings/0001493152-26-039170.md) | [(0.44)](/filings/0001493152-26-027406.md) | not reported | [(0.05)](/filings/0001493152-26-034674.md) | [(0.09)](/filings/0001493152-26-039170.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001493152-24-046866.md) | not reported | [(0.54)](/filings/0001493152-26-027401.md) | [(0.29)](/filings/0001493152-26-027404.md) | [(0.41)](/filings/0001493152-26-027406.md) | not reported | [(0.21)](/filings/0001493152-26-034674.md) | [(0.27)](/filings/0001493152-26-039170.md) | [(0.44)](/filings/0001493152-26-027406.md) | not reported | [(0.05)](/filings/0001493152-26-034674.md) | [(0.09)](/filings/0001493152-26-039170.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.3](/filings/0001493152-23-041332.md) | [0.1](/filings/0001493152-26-027379.md) | [0.3](/filings/0001493152-24-020742.md) | [0.4](/filings/0001493152-24-033050.md) | [0.0](/filings/0001493152-24-046866.md) | [0.1](/filings/0001493152-26-027409.md) | [0.0](/filings/0001493152-26-027401.md) | [4.4](/filings/0001493152-26-027404.md) | [0.8](/filings/0001493152-26-027406.md) | [0.6](/filings/0001493152-26-027409.md) | [0.0](/filings/0001493152-26-034674.md) | [0.0](/filings/0001493152-26-039170.md) |
| Current assets | $m | [7.4](/filings/0001493152-23-041332.md) | [2.4](/filings/0001493152-26-027379.md) | [4.7](/filings/0001493152-24-020742.md) | [4.8](/filings/0001493152-24-033050.md) | [4.8](/filings/0001493152-24-046866.md) | [3.2](/filings/0001493152-26-027409.md) | [3.4](/filings/0001493152-26-027401.md) | [8.9](/filings/0001493152-26-027404.md) | [8.7](/filings/0001493152-26-027406.md) | [6.3](/filings/0001493152-26-039170.md) | [7.8](/filings/0001493152-26-034674.md) | [7.8](/filings/0001493152-26-039170.md) |
| Total assets | $m | [11.1](/filings/0001493152-23-041332.md) | [10.2](/filings/0001493152-26-027379.md) | [9.0](/filings/0001493152-24-020742.md) | [9.3](/filings/0001493152-24-033050.md) | [9.4](/filings/0001493152-24-046866.md) | [8.7](/filings/0001493152-26-027409.md) | [9.0](/filings/0001493152-26-027401.md) | [13.7](/filings/0001493152-26-027404.md) | [13.7](/filings/0001493152-26-027406.md) | [12.4](/filings/0001493152-26-039170.md) | [13.9](/filings/0001493152-26-034674.md) | [13.9](/filings/0001493152-26-039170.md) |
| Current liabilities | $m | [5.6](/filings/0001493152-23-041332.md) | [4.2](/filings/0001493152-26-027379.md) | [4.4](/filings/0001493152-24-020742.md) | [4.5](/filings/0001493152-24-033050.md) | [5.6](/filings/0001493152-24-046866.md) | [6.7](/filings/0001493152-26-027409.md) | [7.2](/filings/0001493152-26-027401.md) | [7.1](/filings/0001493152-26-027404.md) | [7.7](/filings/0001493152-26-027406.md) | [6.0](/filings/0001493152-26-039170.md) | [6.7](/filings/0001493152-26-034674.md) | [7.8](/filings/0001493152-26-039170.md) |
| Total liabilities | $m | [5.7](/filings/0001493152-23-041332.md) | [5.2](/filings/0001493152-26-027379.md) | [4.6](/filings/0001493152-24-020742.md) | [4.7](/filings/0001493152-24-033050.md) | [5.8](/filings/0001493152-24-046866.md) | [6.8](/filings/0001493152-26-027409.md) | [7.3](/filings/0001493152-26-027401.md) | [7.2](/filings/0001493152-26-027404.md) | [7.9](/filings/0001493152-26-027406.md) | [6.2](/filings/0001493152-26-039170.md) | [6.9](/filings/0001493152-26-034674.md) | [7.9](/filings/0001493152-26-039170.md) |
| Long-term debt | $m | not reported | [0.3](/filings/0001493152-24-024452.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.7](/filings/0001493152-26-039170.md) | not reported | [0.7](/filings/0001493152-26-039170.md) |
| Shareholders' equity | $m | [4.7](/filings/0001493152-23-041332.md) | [4.2](/filings/0001493152-26-027379.md) | [4.4](/filings/0001493152-24-020742.md) | [4.6](/filings/0001493152-24-033050.md) | [3.6](/filings/0001493152-24-046866.md) | [1.9](/filings/0001493152-26-027409.md) | [1.6](/filings/0001493152-26-027401.md) | [6.5](/filings/0001493152-26-027404.md) | [5.8](/filings/0001493152-26-027406.md) | [6.2](/filings/0001493152-26-034674.md) | [7.0](/filings/0001493152-26-034674.md) | [6.0](/filings/0001493152-26-039170.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,221) d](/filings/0001493152-24-046866.md) | [(941) d](/filings/0001493152-26-027379.md) | [(872)](/filings/0001493152-26-027401.md) | [(740) d](/filings/0001493152-26-027404.md) | [(1,177) d](/filings/0001493152-26-027406.md) | [(772) d](/filings/0001493152-26-027409.md) | [(776)](/filings/0001493152-26-034674.md) | [(764) d](/filings/0001493152-26-039170.md) | [(4,591) d](/filings/0001493152-26-027406.md) | [(1,791) d](/filings/0001493152-26-027409.md) | [(837)](/filings/0001493152-26-034674.md) | [(828) d](/filings/0001493152-26-039170.md) |
| Capital expenditure | $k | [(0.5) d](/filings/0001493152-23-041332.md) | [(27.0) d](/filings/0001493152-26-027379.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.6](/filings/0001493152-23-041332.md) | [37.3](/filings/0001493152-24-020742.md) | [38.6](/filings/0001493152-24-033050.md) | [38.8](/filings/0001493152-24-046866.md) | [2.7](/filings/0001493152-26-027401.md) | [2.9](/filings/0001493152-26-027404.md) | [3.0](/filings/0001493152-26-027406.md) | [3.1](/filings/0001493152-26-034674.md) | [3.7](/filings/0001493152-26-039170.md) | [4.5](/filings/0001493152-26-027406.md) | [11.6](/filings/0001493152-26-034674.md) | [12.2](/filings/0001493152-26-039170.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,166,106 at 2026-08-19, from the cover of the [10-Q filed 2026-08-19](/filings/0001493152-26-039170.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.